Skip to main content

UBS Group AG

Position in WGS — GeneDx Holdings Corp.

CIK 1610520 ZURICH, V8

Position in WGS

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$3,263,980
-$8,336,069 QoQ
Shares Held
50,825
-43.0% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
10 quarters on record
Voting authority Sole 73.50122970978849.ToString("F0")% Shared 0.ToString("F0")% None 26.49877029021151.ToString("F0")%

Common Shares in WGS Over Time

Shares Held

Position Value (USD)

Derivatives in WGS

reported options exposure · as of Jun 30, 2025
CallValue
$0
CallShares
0
PutValue
$830,790
PutShares
9,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. WGS ranks #26 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in WGS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,263,980 50,825
2025-12-31 $11,600,049 89,190
2025-09-30 $16,138,265 149,789
2025-06-30 $92,468,772 1,001,720
2025-06-30 $830,790 9,000
2025-03-31 $4,617,866 52,141
2024-12-31 $3,605,116 46,905
2024-09-30 $569,374 13,416
2024-06-30 $235,024 8,991
2024-03-31 $3,423 375
2023-09-30 $698 192